NSERecord Date10 Jul 2026 · 10 Jul 2026, 03:23 pm
Record Date
Sudeep Pharma Limited · SUDEEPPHRM
✦ AI SummaryDividend
Sudeep Pharma Limited has announced the record date for the payment of final dividend as July 23, 2026, subject to approval at the 37th Annual General Meeting on August 4, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sudeep Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 23-Jul-2026.
Attachments (1)
📄pdf
Download →
SUDEEPPHARMALIMITED_10072026152040_Update_on_Dividend.pdf
View document text
Date: 10th July 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, C-1, Block G Bandra Kurla Phiroze Jeejeebhoy Towers Dalal Street,
Complex, Bandra (E), Mumbai – 400051 Mumbai – 400001
Scrip Symbol- SUDEEPPHRM Scrip Code: 544619
Sub: Intimation of Record Date for payment of Final Dividend on Equity Shares for the Financial Year
2025-26
Ref: Regulation 30 and 42 of the SEBI (LODR) Regulations, 2015 (Listing Regulations)
Dear Sir/Madam,
As informed earlier, the Board of Directors at its meeting held on Thursday, 21st May 2026, had
recommended a final dividend of ₹1.50/- per equity share of ₹1 each of the Company for approval by the
shareholders at the 37th Annual General Meeting (“AGM”) scheduled to be held on Tuesday, 4th August
2026.
Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, the Company has fixed Thursday, 23rd July 2026 as the
Record Date for determining entitlement of Members to final dividend for the FY 2025-26.
If the final dividend as recommended by the Board of Directors is approved at the AGM, payment of such
dividend, subject to deduction of tax at source, will be paid within stipulated time period, to all Beneficial
Owners in respect of shares held in dematerialized form as per the data as may be made available by
the National Securities Depository Limited and the Central Depository Services (India) Limited as of the
close of business hours on Thursday, 23rd July 2026;
Kindly take note of the same.
Thanking You.
For Sudeep Pharma Limited
Dimple Mehta
Company Secretary & Compliance Officer
M. No.: F13184
CC: 1. National Securities Depository Limited
2. Central Depository Services (India) Limited
3. MUFG Intime India Private Limited
CIN: L24231GJ1989PLC013141
Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India.
Phone No.: +91 265 2840656, 7624095107
Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat,
India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com